Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Antigen-Carrying Bacteria Prime Immune System Against Melanoma
October 29th, 2008
Therapeutic cancer vaccines, while still mostly in early development, are one of the more promising developments in medicine today. A study published in the October 1, 2008 edition of the journal Cancer Research reports some of the most promising results to date on a therapeutic cancer vaccine. Originally targeted to a deadly form of melanoma, the vaccine is broadly effective against a range of common cancers. Researchers, including Dr. Paulo Maciag of North Brunswick, New Jersey-based vaccine biotechnology firm Advaxis, and scientists from the University of Pennsylvania School of Medicine in Philadelphia and the Hillman Cancer Center in Pittsburgh, describe powerful...
Source: Vaccine Weekly (2008-10-29)
|
